Loading...

PE anti-mouse CD11c Antibody PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117308 200 µg NOK1510
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117307 50 µg NOK594
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  2. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  3. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  4. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  5. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  6. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  7. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  8. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  9. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  10. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  11. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  12. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  13. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  14. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  15. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  16. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  17. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  18. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  19. Guo R, et al. 2022. Cells. 12: . PubMed
  20. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  21. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  22. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  23. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  24. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  25. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  26. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  27. Boroumand P, et al. 2022. Elife. 11:. PubMed
  28. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  29. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  30. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  31. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  32. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  33. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  34. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  35. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  36. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  37. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  38. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  39. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  40. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  41. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  42. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  43. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  44. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  45. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  46. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  47. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  48. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  49. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  50. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  51. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  52. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  53. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  54. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  55. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  56. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  57. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  58. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  59. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  60. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  61. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  62. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  63. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  64. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  65. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  66. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  67. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  68. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  69. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  70. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  71. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  72. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  73. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  74. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  75. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  76. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  77. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  78. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  79. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  80. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  81. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  82. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  83. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  84. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  85. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  86. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  87. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  88. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  89. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  90. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  91. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  92. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  93. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  94. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  95. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  96. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  97. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  98. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  99. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  100. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  101. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  102. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  103. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  104. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  105. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  106. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  107. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  108. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  109. De Simone G, et al. 2021. Immunity. :. PubMed
  110. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  111. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  112. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  113. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  114. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  115. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  116. Vorselen D, et al. 2021. Elife. 10:. PubMed
  117. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  118. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  119. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  120. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  121. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  122. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  123. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  124. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  125. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  126. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  127. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  128. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  129. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  130. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  131. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  132. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  133. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  134. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  135. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  136. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  137. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  138. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  139. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  140. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  141. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  142. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  143. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  144. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  145. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  146. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  147. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  148. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  149. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  150. Gu H, et al. 2021. Elife. 10:. PubMed
  151. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  152. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  153. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  154. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  155. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  156. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  157. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  158. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  159. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  160. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  161. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  162. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  163. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  164. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  165. Bussey KA, et al. 2019. J Virol. 93. PubMed
  166. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  167. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  168. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  169. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  170. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  171. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  172. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  173. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  174. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  175. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  176. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  177. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  178. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  179. Jones GS, et al. 2020. mSphere. 5:. PubMed
  180. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  181. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  182. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  183. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  184. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  185. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  186. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  187. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  188. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  189. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  190. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  191. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  192. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  193. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  194. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  195. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  196. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  197. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  198. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  199. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  200. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  201. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  202. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  203. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  204. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  205. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  206. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  207. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  208. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  209. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  210. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  211. Guo R, et al. 2022. Cells. 12: . PubMed
  212. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  213. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  214. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  215. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  216. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  217. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  218. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  219. Boroumand P, et al. 2022. Elife. 11:. PubMed
  220. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  221. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  222. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  223. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  224. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  225. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  226. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  227. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  228. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  229. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  230. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  231. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  232. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  233. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  234. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  235. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  236. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  237. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  238. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  239. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  240. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  241. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  242. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  243. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  244. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  245. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  246. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  247. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  248. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  249. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  250. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  251. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  252. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  253. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  254. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  255. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  256. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  257. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  258. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  259. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  260. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  261. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  262. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  263. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  264. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  265. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  266. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  267. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  268. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  269. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  270. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  271. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  272. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  273. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  274. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  275. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  276. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  277. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  278. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  279. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  280. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  281. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  282. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  283. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  284. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  285. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  286. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  287. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  288. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  289. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  290. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  291. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  292. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  293. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  294. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  295. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  296. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  297. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  298. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  299. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  300. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  301. De Simone G, et al. 2021. Immunity. :. PubMed
  302. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  303. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  304. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  305. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  306. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  307. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  308. Vorselen D, et al. 2021. Elife. 10:. PubMed
  309. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  310. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  311. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  312. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  313. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  314. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  315. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  316. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  317. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  318. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  319. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  320. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  321. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  322. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  323. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  324. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  325. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  326. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  327. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  328. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  329. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  330. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  331. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  332. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  333. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  334. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  335. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  336. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  337. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  338. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  339. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  340. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  341. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  342. Gu H, et al. 2021. Elife. 10:. PubMed
  343. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  344. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  345. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  346. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  347. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  348. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  349. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  350. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  351. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  352. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  353. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  354. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  355. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  356. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  357. Bussey KA, et al. 2019. J Virol. 93. PubMed
  358. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  359. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  360. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  361. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  362. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  363. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  364. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  365. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  366. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  367. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  368. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  369. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  370. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  371. Jones GS, et al. 2020. mSphere. 5:. PubMed
  372. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  373. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  374. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  375. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  376. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  377. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  378. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  379. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  380. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  381. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  382. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  383. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  384. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
RRID
AB_313777 (BioLegend Cat. No. 117308)
AB_313776 (BioLegend Cat. No. 117307)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
Spark YG™ 581 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark YG™ 593 anti-mouse CD11c (Flexi-Fluor™) Antibody N418 FC
Spark PLUS V475™ anti-mouse CD11c Antibody N418 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117308 200 µg NOK1510
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117307 50 µg NOK594
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  2. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  3. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  4. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  5. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  6. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  7. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  8. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  9. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  10. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  11. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  12. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  13. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  14. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  15. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  16. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  17. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  18. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  19. Guo R, et al. 2022. Cells. 12: . PubMed
  20. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  21. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  22. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  23. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  24. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  25. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  26. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  27. Boroumand P, et al. 2022. Elife. 11:. PubMed
  28. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  29. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  30. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  31. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  32. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  33. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  34. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  35. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  36. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  37. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  38. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  39. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  40. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  41. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  42. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  43. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  44. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  45. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  46. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  47. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  48. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  49. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  50. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  51. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  52. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  53. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  54. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  55. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  56. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  57. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  58. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  59. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  60. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  61. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  62. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  63. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  64. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  65. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  66. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  67. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  68. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  69. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  70. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  71. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  72. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  73. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  74. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  75. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  76. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  77. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  78. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  79. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  80. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  81. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  82. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  83. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  84. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  85. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  86. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  87. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  88. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  89. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  90. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  91. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  92. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  93. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  94. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  95. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  96. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  97. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  98. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  99. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  100. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  101. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  102. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  103. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  104. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  105. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  106. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  107. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  108. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  109. De Simone G, et al. 2021. Immunity. :. PubMed
  110. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  111. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  112. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  113. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  114. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  115. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  116. Vorselen D, et al. 2021. Elife. 10:. PubMed
  117. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  118. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  119. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  120. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  121. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  122. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  123. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  124. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  125. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  126. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  127. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  128. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  129. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  130. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  131. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  132. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  133. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  134. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  135. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  136. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  137. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  138. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  139. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  140. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  141. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  142. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  143. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  144. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  145. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  146. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  147. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  148. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  149. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  150. Gu H, et al. 2021. Elife. 10:. PubMed
  151. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  152. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  153. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  154. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  155. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  156. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  157. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  158. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  159. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  160. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  161. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  162. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  163. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  164. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  165. Bussey KA, et al. 2019. J Virol. 93. PubMed
  166. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  167. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  168. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  169. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  170. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  171. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  172. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  173. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  174. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  175. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  176. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  177. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  178. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  179. Jones GS, et al. 2020. mSphere. 5:. PubMed
  180. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  181. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  182. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  183. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  184. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  185. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  186. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  187. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  188. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  189. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  190. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  191. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  192. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  193. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  194. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  195. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  196. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  197. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  198. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  199. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  200. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  201. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  202. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  203. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  204. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  205. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  206. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  207. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  208. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  209. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  210. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  211. Guo R, et al. 2022. Cells. 12: . PubMed
  212. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  213. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  214. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  215. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  216. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  217. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  218. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  219. Boroumand P, et al. 2022. Elife. 11:. PubMed
  220. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  221. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  222. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  223. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  224. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  225. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  226. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  227. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  228. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  229. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  230. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  231. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  232. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  233. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  234. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  235. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  236. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  237. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  238. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  239. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  240. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  241. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  242. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  243. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  244. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  245. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  246. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  247. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  248. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  249. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  250. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  251. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  252. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  253. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  254. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  255. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  256. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  257. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  258. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  259. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  260. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  261. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  262. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  263. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  264. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  265. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  266. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  267. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  268. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  269. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  270. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  271. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  272. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  273. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  274. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  275. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  276. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  277. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  278. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  279. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  280. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  281. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  282. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  283. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  284. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  285. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  286. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  287. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  288. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  289. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  290. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  291. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  292. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  293. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  294. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  295. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  296. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  297. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  298. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  299. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  300. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  301. De Simone G, et al. 2021. Immunity. :. PubMed
  302. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  303. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  304. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  305. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  306. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  307. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  308. Vorselen D, et al. 2021. Elife. 10:. PubMed
  309. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  310. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  311. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  312. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  313. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  314. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  315. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  316. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  317. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  318. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  319. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  320. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  321. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  322. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  323. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  324. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  325. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  326. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  327. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  328. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  329. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  330. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  331. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  332. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  333. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  334. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  335. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  336. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  337. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  338. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  339. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  340. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  341. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  342. Gu H, et al. 2021. Elife. 10:. PubMed
  343. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  344. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  345. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  346. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  347. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  348. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  349. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  350. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  351. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  352. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  353. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  354. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  355. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  356. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  357. Bussey KA, et al. 2019. J Virol. 93. PubMed
  358. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  359. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  360. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  361. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  362. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  363. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  364. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  365. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  366. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  367. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  368. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  369. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  370. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  371. Jones GS, et al. 2020. mSphere. 5:. PubMed
  372. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  373. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  374. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  375. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  376. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  377. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  378. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  379. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  380. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  381. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  382. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  383. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  384. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
RRID
AB_313777 (BioLegend Cat. No. 117308)
AB_313776 (BioLegend Cat. No. 117307)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
Spark YG™ 581 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark YG™ 593 anti-mouse CD11c (Flexi-Fluor™) Antibody N418 FC
Spark PLUS V475™ anti-mouse CD11c Antibody N418 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account